ECS Secures $9.9m Supply Agreement into German Medicinal Cannabis Market

ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”) is pleased to advise that it has entered into a binding three year agreement with German company Ilios Santé GmbH (“Ilios Sante”) for the supply of medicinal cannabis products, which will generate a minimum of $ 9.9m in revenue for the Company.

Highlights:

ECS Botanics executes binding agreement with Ilios Santė GmbH to supply a minimum of AUD 9.9m worth of GMP manufactured, medicinal cannabis products over 3 years
Geíman medicinal cannabis maíket continues to gíow stíongly, with Geíman legislatoís íecently moving to legalise recreational use.

ÉCS’s Head of European Operations, Michael Clark commented:

“Securing an agreement with a long term partner in Germany was an essential building block of ECS`s EU market access strategy. Ensuring that our German partner not only had the necessary narcotic licenses but also has its own clinic network, and the ability to adapt to future changes in cannabis legislation were key elements in securing the agreement. this partnership enables ECS and Ilios Sante to grow an exciting and sustainable business together in Europe`s largest medicinal cannabis market.”

Ilios Sante is based in Frankfurt, Germany. It is a fully licensed wholesale with the authorisations and permissions to import and distribute narcotics and other pharmaceutical products. Its focus is on the procurement and distíibution of medical products containing cannabinoids as an alternative medicine. Ilios Sante is part of the Bloomwell Group, which also includes Algea Care, Germany`s leading platform for therapy with medicinal cannabis.

Under the agreement ECS will exclusively supply 4 medicinal cannabis strains to Ilios Sante with a minimum revenue of $9.9m of GMP manufactured medicinal cannabis products over the following 3 years. First supply is anticipated once product registration has been completed.

Click here for the full ASX Release

This article includes content from ECS Botanics Holdings Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

asx stocks asx:ecs cannabis investing ecs botanics holdings limited

ECS:AU

Trulieve Announces January 2025 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in January.

27 ^th Annual Needham Growth Conference, January 17, 2025 : Vice President of Investor Relations Christine Hersey will participate in a presentation and investor meetings.

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-january-2025-event-participation-302346620.html

SOURCE Trulieve Cannabis Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2025/09/c9006.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Announces January 2025 Event Participation

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in January.

27 ^th Annual Needham Growth Conference, January 17, 2025 : Vice President of Investor Relations Christine Hersey will participate in a presentation and investor meetings.

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-january-2025-event-participation-302346620.html

SOURCE Trulieve Cannabis Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2025/09/c9006.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

10 Biggest Cannabis Stocks in the US and Canada

2024 saw the cannabis industry grappling with persistent challenges, mirroring those of the preceding two years. The absence of meaningful regulatory reform in both the US and Canada continues to stifle market growth

There was some positive momentum in the US as new markets entered the industry and the US Drug Enforcement Administration moved to reschedule cannabis from Schedule I to Schedule III; however, subsequent roadblocks suggest the process could take longer than industry hopefuls originally anticipated.

Cannabis companies in the sector continue to move forward and develop their offerings, and with potential catalysts ahead some investors are interested in getting involved. Looking at the key players is often a good place to get started, so this list of US and Canadian cannabis stocks covers the companies with the largest presence in two major cannabis ETFs.

This list of the biggest publicly traded cannabis companies was put together based on the top-weighted cannabis stocks included in the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) as of December 23, 2024. Share price information for the companies was accurate as of that time.

Keep reading...Show less

ECS Secures $9.9m Supply Agreement into German Medicinal Cannabis Market

US cannabis rescheduling in limbo as new year begins

Cannabis banking reform stalls again in the US

Investor takeaway

US cannabis market

US-focused cannabis fund

1. Green Thumb Industries (CSE:GTII,OTCQX:GTBIF)

2. Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF)

3. Curaleaf Holdings (TSX:CURA,OTCQX:CURLF)

4. Verano Holdings (NEO:VRNO,OTCQX:VRNOF)

5. Cresco Labs (CSE:CL,OTCQX:CRLBF)

Canadian cannabis market

Canada-based cannabis fund

1. Innovative Industrial Properties (NYSE:IIPR)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Cronos Group (NASDAQ:CRON,TSX:CRON)

4. SNDL (NASDAQ:SNDL)

5. Canopy Growth (NASDAQ:CGC,TSX:WEED)

FAQs for investing in cannabis

Are cannabis stocks worth investing in?

Are cannabis stocks considered a high- or low-risk investment?

Why do people buy cannabis stocks?

Latest News

Latest Press Releases

Related News

TOP STOCKS